You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Allo PBSC

Showing 1 - 25 of 549
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematological Malignancies, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (PBSCs, Cord, BMSCs)

Recruiting
  • Hematological Malignancies
  • Hematopoietic Stem Cell Transplantation
  • PBSCs
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 13, 2022

Hematologic Tumors Trial in France (Allogeneic (Allo) hematopoietic stem cell transplantation)

Completed
  • Hematologic Neoplasms
  • Allogeneic (Allo) hematopoietic stem cell transplantation
  • Amiens, France
  • +13 more
Jan 27, 2023

Leukemia Trial in Shanghai (CLAM+PBSC)

Suspended
  • Leukemia
  • Shanghai, China
    Rui Jin Hospital, Department of Hematology
Nov 23, 2021

Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)

Not yet recruiting
  • Allogeneic Disease
  • +2 more
  • WJ-MSC infusion
  • (no location specified)
May 4, 2023

Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Total-Body Irradiation
  • +8 more
  • Los Angeles, California
  • +9 more
Aug 19, 2022

Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Diabetic Foot Ulcer Trial in Bucheon, Seoul (ALLO-ASC-DFU, Vehicle sheet)

Recruiting
  • Diabetic Foot Ulcer
  • ALLO-ASC-DFU
  • Vehicle sheet
  • Bucheon, Gyeonggi-do, Korea, Republic of
  • +3 more
Nov 15, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Cyclophosphamide (Non-IMP, Lymphodepletion)
  • +3 more
  • Ulm, Baden-Württemberg, Germany
  • +4 more
Jul 24, 2023

Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome Trial in Belgium,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
  • Antwerpen, Belgium
  • +21 more
Sep 27, 2021

GVHD Trial in Paris (Cyclophosphamide, Anti-Thymocyte Globulin, Conditioning regimen)

Completed
  • Graft vs Host Disease
  • Paris, France
    Saint Antoine Hospital - Hematology Department
Nov 19, 2020

Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

Recruiting
  • Leukemia, Lymphoid
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Oct 27, 2023

Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))

Not yet recruiting
  • Transplantation, Hematopoietic Stem Cell
  • Biological samples (blood and oral fluid)
  • Lyon, France
    Hôpital de la Croix Rousse - service des maladies infectieuses e
Jul 7, 2023

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,

Recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
May 21, 2021

Relapsed/Refractory Multiple Myeloma Trial in United States (Ipilimumab)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Jan 21, 2022

Alterations in Intestinal Microbiota, Metabolites, and Immune

Recruiting
  • Graft Vs Host Disease
  • Blood Sample
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Nov 16, 2023

Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

Recruiting
  • Myeloid Malignancies
  • fractionated busulfan-based conditioning regimen
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Mar 29, 2023

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

Recruiting
  • Leukemia, Myeloid, Acute
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Dec 27, 2022

Prophylactic HQP1351 Therapy, Third Generation TKI Trial in Guanzhou (HQP1351( Olverembatinib dimesylate))

Withdrawn
  • Prophylactic HQP1351 Therapy
  • Third Generation TKI
  • HQP1351( Olverembatinib dimesylate)
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Jan 16, 2023

CARPET Prognostic Model for Septic Shock After Allo-HSCT

Not yet recruiting
  • Stem Cell Transplant Complications
  • CARPET prognostic model
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Aug 31, 2023

Relapsed/Refractory Large B Cell Lymphoma Trial (biological, drug, genetic)

Not yet recruiting
  • Relapsed/Refractory Large B Cell Lymphoma
  • ALLO-647
  • +3 more
  • (no location specified)
Feb 6, 2023

AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • chidamide and azacitidine
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Sep 27, 2023

Brain Neuronal Networks, Chemosensory and Trigeminal Functions

Recruiting
  • Hematopoietic Stem Cell Transplantation
    • Oslo, Norway
      University of Oslo
    Aug 21, 2023

    Acute Myeloid Leukemia Trial in Hefei (RC1012 injection (allo-DNT cells))

    Recruiting
    • Acute Myeloid Leukemia
    • RC1012 injection (allo-DNT cells)
    • Hefei, Anhui, China
      The First Hospital of the University of Science and Technology o
    May 17, 2023

    Bipolar Depression, MDD Trial in Chi?inau (Palmitoylethanolamide)

    Recruiting
    • Bipolar Depression
    • Major Depressive Disorder
    • Chișinău, Moldova, Republic of
      State University of Medicine and Pharmacy " Nicolae Testemitsanu
    Sep 26, 2023